Close

Oppenheimer Reiterates an 'Outperform' on Curis (CRIS) After Management Reaffirms Story and Pipeline

June 18, 2012 9:53 AM EDT Send to a Friend
Oppenheimer reiterates an 'Outperform' on Curis (NASDAQ: CRIS) price target of $7.50.

Analyst, Boris Peaker, said, "The meeting reaffirmed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login